Complete Genomics Files for IPO

Complete Genomics Inc., a Mountain View, Calif.-based human genome sequencing company, has filed for an $86.25 million IPO. It plans to trade on the Nasdaq under ticker symbol GNOM, with UBS Investment Bank and Jefferies & Co. serving as co-lead underwriters.

The company has raised around $90 million in total VC funding since 2006, from Essex Woodlands Health Ventures, OrbiMed Advisors, Enterprise Partners Venture Capital, OVP Venture Partners, Prospect Venture Partners and Highland Capital Management.

Leave a Reply

PE HUB Community

Join the 12523 members of PE HUB to make connections, share your opinion, and follow your favorite authors.

Join the Community

Look Who’s Tweeting

PE HUB News Briefs

RSS Feed Widget